DK365287A - Fremgangsmaade til dyrkning af bordetella pertussis, pertussis toxoid, pertussis vacciner og fremgangsmaade til fremstilling af pertussis vacciner - Google Patents
Fremgangsmaade til dyrkning af bordetella pertussis, pertussis toxoid, pertussis vacciner og fremgangsmaade til fremstilling af pertussis vaccinerInfo
- Publication number
- DK365287A DK365287A DK365287A DK365287A DK365287A DK 365287 A DK365287 A DK 365287A DK 365287 A DK365287 A DK 365287A DK 365287 A DK365287 A DK 365287A DK 365287 A DK365287 A DK 365287A
- Authority
- DK
- Denmark
- Prior art keywords
- pertussis
- vaccines
- toxoid
- tell
- procedures
- Prior art date
Links
- 201000005702 Pertussis Diseases 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 229940066827 pertussis vaccine Drugs 0.000 title abstract 3
- 108010010803 Gelatin Proteins 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 239000001913 cellulose Substances 0.000 abstract 2
- 229920002678 cellulose Polymers 0.000 abstract 2
- 229920000159 gelatin Polymers 0.000 abstract 2
- 239000008273 gelatin Substances 0.000 abstract 2
- 235000019322 gelatine Nutrition 0.000 abstract 2
- 235000011852 gelatine desserts Nutrition 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241000588832 Bordetella pertussis Species 0.000 abstract 1
- 101710154643 Filamentous hemagglutinin Proteins 0.000 abstract 1
- 108010081690 Pertussis Toxin Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/22—Processes using, or culture media containing, cellulose or hydrolysates thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/832—Bacillus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10236087 | 1987-04-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK365287D0 DK365287D0 (da) | 1987-07-14 |
DK365287A true DK365287A (da) | 1988-10-25 |
Family
ID=14325294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK365287A DK365287A (da) | 1987-04-24 | 1987-07-14 | Fremgangsmaade til dyrkning af bordetella pertussis, pertussis toxoid, pertussis vacciner og fremgangsmaade til fremstilling af pertussis vacciner |
Country Status (10)
Country | Link |
---|---|
US (1) | US4849358A (de) |
EP (1) | EP0287732B1 (de) |
KR (1) | KR900007644B1 (de) |
AT (1) | ATE96036T1 (de) |
CA (1) | CA1337859C (de) |
DE (1) | DE3787887T2 (de) |
DK (1) | DK365287A (de) |
ES (1) | ES2059380T3 (de) |
FI (1) | FI86959C (de) |
NO (1) | NO172188C (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2596413B1 (fr) * | 1986-03-27 | 1988-06-10 | Merieux Inst | Nouveaux milieux de culture de bacteries appartenant au genre bordetella, contenant des derives etherifies de polymeres de d-glucose, et leur application |
US5101019A (en) * | 1987-05-22 | 1992-03-31 | Takeda Chemical Industries, Ltd. | Method for removing pertussis endotoxin, a pertussis toxoid and its production |
JP2849632B2 (ja) * | 1988-04-08 | 1999-01-20 | 社団法人北里研究所 | ワクチン製剤 |
US5000952A (en) * | 1988-08-02 | 1991-03-19 | The Board Of Trustees Of The Leland Stanford, Jr. University | Polypeptide pertussis toxin vaccine |
CA1341123C (en) * | 1988-10-27 | 2000-10-17 | David A. Relman | Filamentous hemagglutinin of b. pertussis |
JP2706792B2 (ja) * | 1988-11-29 | 1998-01-28 | 財団法人化学及血清療法研究所 | 百日咳毒素のトキソイド化法 |
US5578308A (en) * | 1990-02-12 | 1996-11-26 | Capiau; Carine | Glutaraldehyde and formalin detoxified bordetella toxin vaccine |
US5474900A (en) * | 1990-03-16 | 1995-12-12 | Sekisui Chemical Co., Ltd. | Process for preparing purified syphilis antigen from Treponema palljdum |
US5718909A (en) * | 1991-02-18 | 1998-02-17 | Medscand Ab | Sheet containing carbohydrate derivative for removal of E. coli |
AU2088992A (en) * | 1992-05-05 | 1993-11-11 | Research Foundation For Microbial Diseases Of Osaka University, The | Stabilized live vaccine |
CN1147259A (zh) * | 1994-04-28 | 1997-04-09 | 武田药品工业株式会社 | 分离百日咳杆菌保护性组分的方法 |
DE19803453A1 (de) * | 1998-01-30 | 1999-08-12 | Boehringer Ingelheim Int | Vakzine |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB512196A (en) * | 1937-08-19 | 1939-08-30 | Lederle Lab Inc | Method of preparing pertussis toxin and toxoid |
US2359388A (en) * | 1941-02-13 | 1944-10-03 | Lederle Lab Inc | Method of preparing pertussis toxin and toxoid |
DE2461439C3 (de) * | 1974-12-24 | 1980-03-20 | Behringwerke Ag, 3550 Marburg | Verfahren zur Herstellung eines schützenden Antigens von Bordetella Pertussis sowie jenes enthaltendes Mittel |
FR2356429A1 (fr) * | 1976-06-28 | 1978-01-27 | Bertoye Renee | Procede de preparation d'endo-antigenes de bordetella pertussis et bordetella parapertussis utiles notamment au traitement de la coqueluche |
EP0004137B1 (de) * | 1978-02-17 | 1981-11-11 | National Research Development Corporation | Immunologische Zellhüllepräparate |
US4247452A (en) * | 1978-03-01 | 1981-01-27 | The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland | Purification of pertussis haemagglutinins |
JPS5647167A (en) * | 1979-09-26 | 1981-04-28 | Ricoh Co Ltd | Facsimile transmitter |
JPS581482B2 (ja) * | 1980-06-11 | 1983-01-11 | 中松 義郎 | 無加熱反射ライト |
JPS5750925A (en) * | 1980-09-12 | 1982-03-25 | Takeda Chem Ind Ltd | Preparation of pertussis toxoid |
US4500639A (en) * | 1981-10-15 | 1985-02-19 | Teijin Limited | Culturing Bordetella in media containing etherified cyclodextrin |
US4474758A (en) * | 1981-11-19 | 1984-10-02 | American Cyanamid Company | Haemophilus influenzae type b and pertussis outer membrane component combined vaccine |
FR2522268A1 (fr) * | 1982-02-26 | 1983-09-02 | Green Cross Corp | Vaccin anti-ourlien vivant et procede pour le stabiliser |
JPS58222032A (ja) * | 1982-06-18 | 1983-12-23 | Teijin Ltd | 百日咳毒素のサブユニツト蛋白 |
JPS59110626A (ja) * | 1982-12-17 | 1984-06-26 | Kaken Pharmaceut Co Ltd | B−オリゴマ−含有百日咳ワクチンおよびその製造方法 |
HU188847B (en) * | 1983-02-22 | 1986-05-28 | Human Oltoanyagtermeloe Es Kutato Intezet,Hu | Process for producing liophylized combined vaccines |
JPS59175439A (ja) * | 1983-03-23 | 1984-10-04 | Teijin Ltd | 繊維状赤血球凝集素の製法 |
CA1213234A (en) * | 1983-03-30 | 1986-10-28 | Akihiro Ginnaga | Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine |
US4551429A (en) * | 1983-09-15 | 1985-11-05 | American Home Products Corporation | Stimulation of antigen production by Bordetella pertussis |
JPS6098988A (ja) * | 1983-11-01 | 1985-06-01 | Chemo Sero Therapeut Res Inst | Lpf−haの精製法 |
JPS60226822A (ja) * | 1984-04-25 | 1985-11-12 | Chemo Sero Therapeut Res Inst | 線維状赤血球凝集素の精製方法 |
US4563303A (en) * | 1984-04-14 | 1986-01-07 | Judicial Foundation The Chemosero-Therapeutic Research Institute | Method for purification of filamentous hemagglutinin |
JPS60237027A (ja) * | 1984-05-07 | 1985-11-25 | Chemo Sero Therapeut Res Inst | 線維状赤血球凝集素の精製方法 |
JPS60218326A (ja) * | 1984-04-14 | 1985-11-01 | Chemo Sero Therapeut Res Inst | 線維状赤血球凝集素の精製方法 |
GB8412207D0 (en) * | 1984-05-12 | 1984-06-20 | Wellcome Found | Antigenic preparations |
JPS6176422A (ja) * | 1984-09-22 | 1986-04-18 | Chemo Sero Therapeut Res Inst | 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法 |
GB8512972D0 (en) * | 1985-05-22 | 1985-06-26 | Univ Glasgow | Vaccine production |
GB8601279D0 (en) * | 1986-01-20 | 1986-02-26 | Public Health Lab Service | Purification of pertussis antigens |
FR2596413B1 (fr) * | 1986-03-27 | 1988-06-10 | Merieux Inst | Nouveaux milieux de culture de bacteries appartenant au genre bordetella, contenant des derives etherifies de polymeres de d-glucose, et leur application |
US4705686A (en) * | 1986-05-09 | 1987-11-10 | American Cyanamid | Process for the preparation of acellular Bordetalla pertussis vaccine |
US4699786A (en) * | 1986-05-09 | 1987-10-13 | American Cyanamid Company | Enhanced large scale cultivation of bordetella pertussis cells for vaccine production using lactoglobulin |
JP2537042B2 (ja) * | 1986-11-27 | 1996-09-25 | 社団法人北里研究所 | ボルデテラ・ブロンキセプチカ感染症生菌ワクチン用原株の製造法および生菌ワクチン |
JPH0628277A (ja) * | 1992-07-10 | 1994-02-04 | Nec Software Ltd | ファイル転送装置 |
JP3240711B2 (ja) * | 1992-11-11 | 2001-12-25 | ソニー株式会社 | Y/c分離フィルタ装置 |
-
1987
- 1987-07-09 CA CA000541661A patent/CA1337859C/en not_active Expired - Lifetime
- 1987-07-13 AT AT87306165T patent/ATE96036T1/de not_active IP Right Cessation
- 1987-07-13 EP EP87306165A patent/EP0287732B1/de not_active Expired - Lifetime
- 1987-07-13 DE DE87306165T patent/DE3787887T2/de not_active Expired - Lifetime
- 1987-07-13 ES ES87306165T patent/ES2059380T3/es not_active Expired - Lifetime
- 1987-07-13 FI FI873083A patent/FI86959C/fi not_active IP Right Cessation
- 1987-07-13 NO NO872919A patent/NO172188C/no not_active IP Right Cessation
- 1987-07-14 DK DK365287A patent/DK365287A/da not_active Application Discontinuation
- 1987-07-14 US US07/073,134 patent/US4849358A/en not_active Expired - Lifetime
- 1987-07-30 KR KR1019870008356A patent/KR900007644B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI86959C (fi) | 1992-11-10 |
DE3787887D1 (de) | 1993-11-25 |
EP0287732B1 (de) | 1993-10-20 |
FI86959B (fi) | 1992-07-31 |
KR900007644B1 (ko) | 1990-10-17 |
ATE96036T1 (de) | 1993-11-15 |
KR880012238A (ko) | 1988-11-26 |
NO872919D0 (no) | 1987-07-13 |
DK365287D0 (da) | 1987-07-14 |
ES2059380T3 (es) | 1994-11-16 |
NO172188B (no) | 1993-03-08 |
NO872919L (no) | 1988-10-25 |
NO172188C (no) | 1993-06-16 |
FI873083A0 (fi) | 1987-07-13 |
US4849358A (en) | 1989-07-18 |
FI873083A (fi) | 1988-10-25 |
CA1337859C (en) | 1996-01-02 |
DE3787887T2 (de) | 1994-02-10 |
EP0287732A1 (de) | 1988-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK365287A (da) | Fremgangsmaade til dyrkning af bordetella pertussis, pertussis toxoid, pertussis vacciner og fremgangsmaade til fremstilling af pertussis vacciner | |
DE69020422D1 (de) | Zusammensetzung in Form eines Schaumes enthaltend 5-Aminosalicylic Säure zur intra-rektal Verabreichung. | |
DK208985A (da) | Antigent praeparat og fremgangsmaade til isolering af et saadant praeparat | |
DK174931B1 (da) | Lægemiddel med langsom frigivelse af den aktive bestanddel | |
EP0202947A3 (de) | Impfstoffproduktion | |
LU91155I2 (fr) | Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutininine filamenteuse, de pertactine, d'agglutinogènes fimbriaux coquelucheux 2 et 3 et de virus poliomyélitique inactivé type 1, type 2 et type 3. | |
DK0515415T3 (da) | Hidtil ukendt vaccine og fremgangsmåde til fremstilling deraf | |
NO169820C (no) | Fremgangsmaate for fremstilling av en mastittvaksine | |
NO913131L (no) | Immunogene konjugater av ikke-toksisk oligosakkarid fra bordetella pertussis lipoolysakkarid. | |
Davidson et al. | Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals | |
DE68917972D1 (de) | Pertussistoxoid-Impfstoff. | |
DK516781A (da) | Racemiske eller optisk aktive bicyclo (2,2,1) heptanderivater deres fremstilling og anvendelse som plantevaekstregulerende midler | |
NL194960B (nl) | Werkwijze voor het bereiden van mutantstammen van Bordetella bronchiseptica en daarop gebaseerd levend verzwakt vaccin. | |
GB9611501D0 (en) | Vaccine compositions | |
Felfe et al. | Trends in production of foot-and-mouth disease vaccine. | |
Nenkov et al. | Standardization of cholera vaccine, obtaining of a national reference preparation. | |
BG28243A3 (en) | Incecticide means | |
FR2601250B1 (fr) | Procede de preparation de fractions antigeniques exocellulaires de bordetella pertussis et vaccin contre la coqueluche contenant de telles fractions. | |
JPS53109912A (en) | Condensed tannin, inactivation of microorganism-originated toxic substance, and attenuation of vaccines using condensed tannin | |
EP0178928A3 (de) | Impfstoffe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHS | Application shelved for other reasons than non-payment |